CCL2 is known to promote cancer development by facilitating the attraction of microglia, circulating monocytes, and myeloid-derived suppressor cells to the tumor area [9,10,47], whereas GM-CSF promotes the proliferation of TIM [48]. The gene discussed is CSF2; the disease is neoplasm.